ARCHIVES

Medicare Should Pay Routine Care For Patients in Trials: IOM.

This article is from The Cancer Letter archive.

Vol. 26 No. 01 | January 7, 2000

Download PDF Visit The Full Archive

Related Articles

Cancer Control RFA Announcements

March 9, 1979

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980

Varmus Pledges No Funding Gap for NCORP, Blames Snafu On “Unclear Communication”

April 11, 2014

Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin.

January 21, 2005

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

June 30, 2006

Gene Therapy Appears to Benefit Two Children With ADA Deficiency, Scientist Tells Writers

April 9, 1993